99 related articles for article (PubMed ID: 9678429)
1. Effect of glucose on matrix metalloproteinase activity in mesangial cells.
McLennan SV; Yue DK; Turtle JR
Nephron; 1998; 79(3):293-8. PubMed ID: 9678429
[TBL] [Abstract][Full Text] [Related]
2. Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy.
McLennan SV; Martell SK; Yue DK
Diabetes; 2002 Aug; 51(8):2612-8. PubMed ID: 12145178
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy.
McLennan SV; Wang XY; Moreno V; Yue DK; Twigg SM
Endocrinology; 2004 Dec; 145(12):5646-55. PubMed ID: 15345671
[TBL] [Abstract][Full Text] [Related]
4. High glucose reduces generation of plasmin activity by mesangial cells.
Fisher EJ; McLennan SV; Yue DK; Turtle JR
Microvasc Res; 1997 Mar; 53(2):173-8. PubMed ID: 9143550
[TBL] [Abstract][Full Text] [Related]
5. Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy.
McLennan SV; Fisher E; Martell SY; Death AK; Williams PF; Lyons JG; Yue DK
Kidney Int Suppl; 2000 Sep; 77():S81-7. PubMed ID: 10997695
[TBL] [Abstract][Full Text] [Related]
6. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade.
Baricos WH; Cortez SL; el-Dahr SS; Schnaper HW
Kidney Int; 1995 Apr; 47(4):1039-47. PubMed ID: 7540230
[TBL] [Abstract][Full Text] [Related]
7. The role of the mesangial cell and its matrix in the pathogenesis of diabetic nephropathy.
McLennan SV; Death AK; Fisher EJ; Williams PF; Yue DK; Turtle JR
Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):123-35. PubMed ID: 10099846
[TBL] [Abstract][Full Text] [Related]
8. High glucose concentration causes a decrease in mesangium degradation. A factor in the pathogenesis of diabetic nephropathy.
McLennan SV; Fisher EJ; Yue DK; Turtle JR
Diabetes; 1994 Aug; 43(8):1041-5. PubMed ID: 8039598
[TBL] [Abstract][Full Text] [Related]
9. High glucose concentration inhibits the expression of membrane type metalloproteinase by mesangial cells: possible role in mesangium accumulation.
McLennan SV; Martell SY; Yue DK
Diabetologia; 2000 May; 43(5):642-8. PubMed ID: 10855539
[TBL] [Abstract][Full Text] [Related]
10. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1.
Singh R; Song RH; Alavi N; Pegoraro AA; Singh AK; Leehey DJ
Exp Nephrol; 2001; 9(4):249-57. PubMed ID: 11423724
[TBL] [Abstract][Full Text] [Related]
11. Decreased degradative enzymes in mesangial cells cultured in high glucose media.
Leehey DJ; Song RH; Alavi N; Singh AK
Diabetes; 1995 Aug; 44(8):929-35. PubMed ID: 7621999
[TBL] [Abstract][Full Text] [Related]
12. Role of plasmin and gelatinase in extracellular matrix degradation by cultured rat mesangial cells.
Wong AP; Cortez SL; Baricos WH
Am J Physiol; 1992 Dec; 263(6 Pt 2):F1112-8. PubMed ID: 1481887
[TBL] [Abstract][Full Text] [Related]
13. High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells.
Ayo SH; Radnik RA; Garoni JA; Glass WF; Kreisberg JI
Am J Pathol; 1990 Jun; 136(6):1339-48. PubMed ID: 2356864
[TBL] [Abstract][Full Text] [Related]
14. Soluble latent membrane-type 1 matrix metalloprotease secreted by human mesangial cells is activated by urokinase.
Kazes I; Delarue F; Hagège J; Bouzhir-Sima L; Rondeau E; Sraer JD; Nguyen G
Kidney Int; 1998 Dec; 54(6):1976-84. PubMed ID: 9853262
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of the mesangial matrix metalloproteinase-2 impairs gelatinolytic activity.
Mattana J; Margiloff L; Sharma P; Singhal PC
Inflammation; 1998 Jun; 22(3):269-76. PubMed ID: 9604714
[TBL] [Abstract][Full Text] [Related]
17. Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy.
Min D; Lyons JG; Bonner J; Twigg SM; Yue DK; McLennan SV
Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1229-37. PubMed ID: 19741020
[TBL] [Abstract][Full Text] [Related]
18. Simulated glomerular pressure modulates mesangial cell 72 kDa metalloproteinase activity.
Singhal PC; Sagar S; Garg P
Connect Tissue Res; 1996; 33(4):257-63. PubMed ID: 8834443
[TBL] [Abstract][Full Text] [Related]
19. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium.
Ayo SH; Radnik RA; Glass WF; Garoni JA; Rampt ER; Appling DR; Kreisberg JI
Am J Physiol; 1991 Feb; 260(2 Pt 2):F185-91. PubMed ID: 1996670
[TBL] [Abstract][Full Text] [Related]
20. BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions.
Suzaki Y; Yoshizumi M; Kagami S; Nishiyama A; Ozawa Y; Kyaw M; Izawa Y; Kanematsu Y; Tsuchiya K; Tamaki T
Kidney Int; 2004 May; 65(5):1749-60. PubMed ID: 15086914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
